Rentschler Holding has sold all of the shares of Rentschler Pharma to Riemser Arzneimittel in Greifswald/Isle of Riems, eastern Germany
Rentschler will invest another euro14 million in the expansion of Rentschler Biotechnologie at the Laupheim site.
Only recently a euro50 million investment in biotechnological development and production facilities was completed.
The first sod will already be taken this year for the new construction of a logistics centre and the expansion of the administrative building in Erwin-Rentschler-Strasse in Laupheim.
In the logistics centre a high-rise warehouse, several cold warehouses, an incoming goods department, a dispatch area and the company's transport fleet will be located.
The move into the new buildings is planned for end of 2009.
With this step, Rentschler concentrates all of the biotech activities at one site and thus provides the frame for further growth.
Within the scope of this business concentration on the development and manufacture of biopharmaceutical drug products Riemser is planning to further expand its business division contract manufacture from the Laupheim site.
In this connection Rentschler Pharma will be renamed to Riemser Speciality Production .
